The Atlantic Nano Forum presents

Tiny Technology....Big Results

with a presentation from
Donald A. Tomalia, Ph.D., President and Chief Technical Officer, Dendritic Nanotechnologies.

Date: Thursday, May 26, 2005
Time: Registration begins at 4:00 PM; program begins at 4:30 PM
Cost: Attendance is free
Location: Burns, Doane, Swecker & Mathis, L.L.P.
Suite 500, 1737 King Street, Alexandria, Virginia 22314
Click here for directions, or visit www.burnsdoane.com/alex.html
Info: For more information, send mail to nano@burnsdoane.com
Registration: Please register using the RSVP link, or send an email to nano@burnsdoane.com.

Panelist
Donald A. Tomalia, Ph.D., President and Chief Technical Officer,

Dendritic Nanotechnologies.

Dr. Tomalia launched his academic and entrepreneurial ventures after a 25-year management and senior scientist career with The Dow Chemical Company. During that time, he was credited with numerous commercial developments which included Citrucel® (now marketed by GlaxoSmithKline), cationic polymerization of 2-oxazolines and discovery of the fourth major class of macromolecular architecture; namely, “dendritic polymers.” He is the inventor and originator of the term “dendrimers,” and is listed on over 100 U.S. patents and more than 180 peer reviewed publications. Over 150 of these publications are focused on the dendrimer and dendritic polymer field, including a monograph entitled “Dendrimers and Other Dendritic Polymers.” Dr. Tomalia serves as the president and CTO of DNT while he remains active in the academic community as distinguished visiting professor (Columbia University), distinguished research scientist/professor (Central Michigan University), Co-Director of the “National Center for Dendrimer Based Nanotechnology” (Central Michigan University) and serves on the editorial advisory boards of Bioconjugate Chemistry and NanoLetters.

Dendritic NanoTechnologies Inc. (DNT) is the world’s leading developer and provider of advanced dendritic polymers. DNT has breakthrough technology that provides the vehicle — the targeting and delivery mechanisms — for a vast array of diagnostics and therapeutics currently in development in the biotechnology and pharmaceutical industries.

For more information, please visit www. dnanotech.com/index.php.

 Agenda
4:00 – 4:25 Refreshments, registration
4:25 – 4:30 Introduction
4:30 – 5:30 Presentation by Dr. Tomalia, followed by Q&A
  

 About the Emerging Tech Forum
The forum features monthly presentations by eminent nanotechnologists and provides educational, networking, and business opportunities to those interested in this emerging field. The attendees include patent examiners, CTOs, researchers, policy makers, federal and state government employees, venture capitalists, entrepreneurs and industry executives.

 Future Events
Future meetings are also planned for Nano Medicine, Nano Electronics, Nano Investing, Sources of government funding for emerging technologies.

With Participation From

If you do not wish to receive future communications from Emerging Tech Forum, please click here to unsubscribe, and we will immediately remove your name from our mailing list.